Related Experiment Video
Updated: May 1, 2026

Methods for Evaluating the Role of c-Fos and Dusp1 in Oncogene Dependence
Published on: January 7, 2019
Oncogene c‑Myc: From molecular mechanism to targeted therapy (Review)
Jianjun Lu1, Jing Zhu2, Liqiong Zhang2
1Department of Pathology, Suzhou Ninth People's Hospital, Suzhou, Jiangsu 215200, P.R. China.
None:
c‑Myc, a member of the MYC family, is an extensively studied proto‑oncogenic transcription factor that plays crucial roles in various biological processes of tumor cells, including proliferation, cell cycle regulation, DNA damage repair, metabolic reprogramming, differentiation and genomic maintenance. Furthermore, in cancer therapeutics, c‑Myc may serve as a key factor influencing targeted drug efficacy and tumor drug resistance. This review comprehensively summarizes the structural characteristics of c‑Myc and its roles and key molecular mechanisms across various malignancies, as well as current strategies for c‑Myc‑targeted therapies and related clinical trials. Additionally, the existing challenges in c‑Myc research are discussed and future research directions are being outlined. The synthesis aims to provide novel insights for fundamental research, offer new perspectives for precision cancer therapy in clinical practice and ultimately bring renewed hope for cancer treatment.
Related Concept Videos
Abnormal Proliferation
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Induced Pluripotent Stem Cells
Somatic...
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
Cancer-Critical Genes I: Proto-oncogenes

